Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report

eJHaem(2024)10.1002/jha2.1041Source: DataRank Database

Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report is a research paper published in eJHaem (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

pxd

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 0.00)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Megan Othus ORCID,Chenwei Lin ORCID,Melinda A. Biernacki ORCID,Marie Bleakley ORCID,Thomas R. Chauncey ORCID

Live enrichment

PubMed:39691254 PMC:PMC11647701 OpenAlex:https://openalex.org/W4403769905

NCI NIH HHS

Grant: U01 CA271407

NCI NIH HHS

Grant: R50 CA211499

NCI NIH HHS

Grant: U01 CA214114

NCI NIH HHS

Grant: P30 CA015704

National Institutes of Health

Grant: 5P01CA018029-36

Targeting Alloreactivity for Leukemia Eradication

National Institutes of Health

Grant: 2U10CA180819-06

SWOG Statistics and Data Management Center

National Institutes of Health

Grant: 5R01CA160872-04

Discovery and Optimization of AML Prognostic Biomarkers

National Institutes of Health

Grant: 5U01CA271407-04

Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies

National Institutes of Health

Grant: 5R01CA190661-02

Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype

National Institutes of Health

Grant: 3P30CA015704-42S2

Cancer Center Support Grant

National Institutes of Health

Grant: 3U10CA180888-03S1

SWOG Network Group Operations Center of the NCTN

National Institutes of Health

Grant: 1R50CA211499-01

A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer

National Institutes of Health

Grant: 3U01CA214114-05S1

Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit

National Institutes of Health

Grant: 5U24CA196175-10

SWOG Biospecimen Bank to Support NCI NCTN

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jha2.1041

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jha2.1041

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.1041

journalhttps://doi.org/10.1002/jha2.1041

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39691254

Fields of Study

Acute Myeloid Leukemia ResearchAdvanced Proteomics Techniques and Applicationsvaccines and immunoinformatics approaches0303 health sciences03 medical and health sciences

Keywords

BiologyProteomeProteogenomicsMyeloid leukemiaProteomicsTranscriptomeComputational biologyHaematopoiesisIn silicoMyeloidCancer researchGeneBioinformaticsGene expressionGeneticsStem cellAMlHematological malignancyTranscriptomicsNeoantigensHaematologic Malignancy ‐ MyeloidDiseases of the blood and blood-forming organsRC633-647.5

Sustainable Development Goals

SDG 0: Good health and well-being